BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7731709)

  • 1. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.
    Snudden DK; Smith PR; Lai D; Ng MH; Griffin BE
    Oncogene; 1995 Apr; 10(8):1545-52. PubMed ID: 7731709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Yates JL; Camiolo SM; Ali S; Ying A
    Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
    Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
    Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT; Chen W; Hsu MM; Dee AN
    Lab Invest; 1997 Jun; 76(6):793-8. PubMed ID: 9194855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8.
    Do NV; Ingemar E; Phi PT; Jenny A; Chinh TT; Zeng Y; Hu L
    Virus Res; 2008 Mar; 132(1-2):15-24. PubMed ID: 18096263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhanced transcriptional activity of the V-val subtype of Epstein-Barr virus nuclear antigen 1 in epithelial cell lines.
    Mai SJ; Xie D; Huang YF; Wang FW; Liao YJ; Deng HX; Liu WJ; Hua WF; Zeng YX
    Oncol Rep; 2010 May; 23(5):1417-24. PubMed ID: 20372859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functions of V-val subtype of Epstein-Barr nuclear antigen 1].
    Mai SJ; Li DJ; Zhou XX; Chen LZ; Feng QS; Zhang RH; Yu XJ; Zeng YX
    Ai Zheng; 2008 Mar; 27(3):231-6. PubMed ID: 18334109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV gene expression in an NPC-related tumour.
    Hitt MM; Allday MJ; Hara T; Karran L; Jones MD; Busson P; Tursz T; Ernberg I; Griffin BE
    EMBO J; 1989 Sep; 8(9):2639-51. PubMed ID: 2479554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line.
    Mai SJ; Ooka T; Li DJ; Zeng MS; Jiang RC; Yu XJ; Zhang RH; Chen SP; Zeng YX
    Oncol Rep; 2007 Jan; 17(1):141-6. PubMed ID: 17143491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EBNA1 in NPC tumourigenesis.
    Frappier L
    Semin Cancer Biol; 2012 Apr; 22(2):154-61. PubMed ID: 22206863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue.
    Liu MY; Shih YY; Li LY; Chou SP; Sheen TS; Chen CL; Yang CS; Chen JY
    J Med Virol; 2000 Jun; 61(2):241-50. PubMed ID: 10797381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.